Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus

被引:47
|
作者
Canonica, Giorgio Walter [1 ,2 ]
Blasi, Francesco [3 ,4 ,5 ]
Carpagnano, Giovanna Elisiana [6 ,7 ]
Guida, Giuseppe [8 ,9 ]
Heffler, Enrico [1 ,2 ]
Paggiaro, Pierluigi [10 ]
Allegrini, Chiara [11 ]
Antonelli, Andrea [12 ]
Aruanno, Arianna [13 ]
Bacci, Elena [14 ]
Bagnasco, Diego [15 ]
Beghe, Bianca [16 ]
Bonavia, Marco [17 ]
Bonini, Matteo [18 ]
Brussino, Luisa [19 ]
Caiaffa, Maria Filomena [20 ]
Calabrese, Cecilia [21 ]
Camiciottoli, Gianna [11 ]
Caminati, Marco [22 ]
Caruso, Cristiano [13 ,23 ]
Cavallini, Mirta [24 ]
Bianchi, Fulvia Chieco [25 ]
Conte, Maria Elisabetta [26 ]
Corsico, Angelo Guido [27 ]
Cosmi, Lorenzo [28 ]
Costantino, Mariateresa [29 ]
Costanzo, Giulia [30 ]
Crivellaro, Mariaangiola [25 ]
D'Alo, Simona [31 ]
D'Amato, Mariella [32 ]
Detoraki, Aikaterini [33 ]
Di Proietto, Maria Carmela [33 ]
Facciolongo, Nicola Cosimo [35 ]
Ferri, Sebastian [1 ]
Fierro, Vincenzo [36 ]
Foschino, Maria Pia [37 ]
Latorre, Manuela [38 ]
Lombardi, Carlo [39 ]
Macchia, Luigi [40 ]
Milanese, Manlio [41 ]
Montagni, Marcello [42 ]
Parazzini, Elena Maria [43 ]
Parente, Roberta [44 ]
Passalacqua, Giovanni [45 ]
Patella, Vincenzo [46 ]
Pelaia, Girolamo [47 ]
Pini, Laura [48 ]
Puggioni, Francesca [1 ]
Ricciardi, Luisa [49 ]
Ridolo, Erminia [50 ]
机构
[1] IRCCS Humanitas Res Hosp, Personalized Med Asthma & Allergy, Via Manzoni 56, I-20089 Milan, Italy
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore, Resp Unit, Policlin Milano, Milan, Italy
[4] Policlin Milano, Fdn IRCCS Ca Granda Osped Maggiore, Cyst Fibrosis Ctr, Milan, Italy
[5] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[6] Univ Bari Aldo Moro, Dept Translat Biomed & Neurosci DiBraiN, Bari, Italy
[7] Policlin Hosp Bari, Sect Resp Dis, Bari, Italy
[8] Univ Turin, Dept Clin & Biol Sci, Turin, Italy
[9] San Luigi Gonzaga Univ Hosp, Severe Asthma & Rare Lung Dis Unit, Orbassano, Italy
[10] Univ Pisa, Dept Surg Med Mol Biol & Crit Care, Pisa, Italy
[11] Azienda Osped Univ Careggi, Ambulatorio Asma Grave Pneumol & Fisiopatol Toraco, Azienda Ospedaliera Universitaria Careggi, Florence, Italy
[12] Osped S Croce & Carle, Responsabile SS Allergol & Fisiopatol Resp, Cuneo, Italy
[13] Univ Cattolica Roma, Ist Clin Med, Allergol, Policlin Gemelli, Rome, Italy
[14] Fisiopatol Resp & Riabilitaz, Azienda Osped Univ Pisana, Pisa, Italy
[15] UO Clin Malattie Respiratorie & Allergol, UO Clin Malattie Resp & Allergol, San Martino Buon Albergo, Italy
[16] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Maternal Infant & Adult, Sect Resp Dis, Emilia Romagna, Italy
[17] Osped Colletta, Dipartimento Special Med, SS Pneumol Riabilitat, SC Pneumol, Genoa, Italy
[18] Fdn Policlin Univ A Gemelli, UOC Pneumol, IRCCS, Rome, Italy
[19] SSDDU Immunol Clin Allergol, SSDDU Immunol Clin & Allergol, Turin, Italy
[20] Azienda Osped Univ, Dipartimenti funzioni Med & Sanitarie, Azienda Ospedaliero Universitaria, Osped Riuniti, Foggia, Italy
[21] Azienda Osped Specialist Colli, Dipartimento Pneumol & Oncol, UO Clin Pneumol SUN, Naples, Italy
[22] Azienda Osped Univ Integrata Verona, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy
[23] Fdn Policlin A Gemelli IRCCS, UOSD DH Internal Med & Digest Dis, Rome, Italy
[24] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Broncopneumol, Milan, Italy
[25] UOC Fisiopaol Respiratoria, UOC Fisiopaol Resp, Padua, Italy
[26] Struttura Complessa Pneumol, Azienda Assistenza Sanit 5 Friuli Occidentale, Pordenone, Italy
[27] Fdn IRCCS Policlin San Matteo, UOC Pneumol, Pavia, Italy
[28] AOUC Azienda Osped Univ Careggi, AOUC Azienda Ospedaliero Universitaria Careggi, Florence, Italy
[29] ASST Azienda Socio Sanitaria Terr Mantova, Osped Carlo Poma, Dipartimento Med, Ctr Day Hosp,Allergol & Immunol Clin, Mantua, Italy
[30] Policlin Univ Cagliari, Allergol & Immunol Clin, Cagliari, Italy
[31] UO Allergol, Azienda Sanit Unica Reg Marche, Civitanova Marche, Marche, Italy
[32] Azienda Osped Colli, UOC Pneumofisiol, Univ Federico II, Naples, Italy
[33] UODS Allergol Immunodeficienze, Azienda Osped Univ Federico II, Naples, Italy
[34] ASST Grande Osped Metropolitano Niguarda, SC Pneumol, Milan, Italy
[35] UOC Pneumol, Arcispedale S Maria Nuova Azienda USL Reggio Emili, Emilia Romagna, Italy
[36] Osped Pediat Bambino Gesu, UOC Allergol, Rome, Italy
[37] Azienda Osped Univ, Azienda Ospedaliera Universitaria, Foggia, Italy
[38] Osped Nuovo Apuano Massa, UO Pneumol, Massa, Italy
[39] Fdn Poliambulanza Ist Osped, Unita Allergol Immunol & Malattie Resp, Brescia, Italy
[40] Un Dipartimentale Allergol & Immunol Clin, Unita Dipartimentale Allergol & Immunol Clin, Bari, Italy
[41] Osped S Corona, Dipartimento Special Med, SC Pneumol, Pietra Ligure, Savona, Italy
[42] Osped G Saliceto Piacenza, Piacenza, Italy
[43] St i Paolo & Carlo Hosp, Otolaryngol Unit, Milan, Italy
[44] AOU San Giovanni di Dio & Ruggi di Aragona, Salerno, Italy
[45] Aou San Martino Ist Ge, IRCCS, Dip Med Interna, Genoa, Italy
[46] UO Allergol Immunol Clin, Azienda Sanit, Florence, Italy
[47] AOU Mater Domini, Catanzaro, Italy
[48] ASST Spedali Civili Brescia, UOC, Med Gen 2, Brescia, Italy
[49] Univ Messina, Dept Neurosurg, AOU Policlin G Martino, Messina, Italy
[50] Azienda Osped Univ Parma, Ambulatorio Allergol & Immunol Clin, AziendaOspedaliero, Parma, Italy
关键词
Asthma; Asthma remission; Allergy; Inflammation; Delphi analysis; MANAGEMENT;
D O I
10.1016/j.jaip.2023.07.041
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
analysis. Thirty-two statements were included in the R1 questionnaire and then submitted to a panel of 80 experts, which used a 5 -point Likert scale to measure agreement regarding each statement. Then, an interim analysis of R1 data was performed, and items were discussed and considered to produce a consistent questionnaire for round 2 (R2) of the analysis. Then, the board set the R2 questionnaire, which included only important topics. Panelists were asked to vote on the statements in the R2 questionnaire afterward. During R2, the criteria of complete clinical remission (the absence of the need for oral corticosteroids, symptoms, exacerbations or attacks, and pulmonary function stability) and those of partial clinical remission (the absence of the need for oral corticosteroids, and two of three criteria: the absence of symptoms, exacerbations or attacks, and pulmonary stability) were confirmed. This Severe Asthma Network Italy Delphi analysis defined a valuable and independent tool that is easy to use, to test the efficacy of different treatments in patients with severe asthma enrolled into the SANI registry. (c) 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY -NC -ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/). (J Allergy Clin Immunol Pract 2023;11:3629-37)
引用
收藏
页码:3629 / 3637
页数:9
相关论文
共 50 条
  • [21] Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry
    Caminati, Marco
    Guarnieri, Gabriella
    Paggiaro, Pierluigi
    Vianello, Andrea
    Crisafulli, Ernesto
    Vaia, Rachele
    Senna, Gianenrico
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [22] Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
    Caminati, Marco
    Marcon, Alessandro
    Vaia, Rachele
    Senna, Gianenrico
    Maule, Matteo
    Marchetti, Pierpaolo
    Miotti, Jessica
    Argentino, Giuseppe
    Blasi, Francesco
    Canonica, Giorgio W.
    Paggiaro, Pierluigi
    Heffler, Enrico M.
    Vianello, Andrea
    Guarnieri, Gabriella
    WORLD ALLERGY ORGANIZATION JOURNAL, 2024, 17 (08):
  • [23] Biomarker-based corticosteroid adjustment in severe asthma: a modified Delphi consensus
    Gallagher, Nicola E.
    Hanratty, Catherine E.
    Humbert, Marc
    Bel, Elisabeth
    Djukanovic, Ratko
    Hudson, Valerie
    Amos, Nile
    Heaney, Liam G.
    ERJ OPEN RESEARCH, 2018, 4 (04)
  • [24] Impact of baseline characteristics on clinical remission achievement in severe asthma
    Domingo Ribas, C.
    Pavord, I
    Banas Conejero, D.
    Price, R. G.
    Pullan, A.
    Oppenheimer, J.
    Heaney, L. G.
    Nagase, H.
    Pizzichini, E.
    Howarth, P.
    Gardiner, F.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [25] Clinical remission in severe asthma: lights and shadows on an ambitious goal
    Pelaia, Corrado
    Zannoni, Eleonora
    Paoletti, Giovanni
    Marzio, Valentina
    Heffler, Enrico
    Carron-Herrero, Alejandra
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 24 (04) : 230 - 236
  • [26] Biologic Super-Response and Clinical Remission in Severe Asthma
    Denton, Eve
    Hew, Mark
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (09): : 2713 - 2714
  • [27] A multistakeholder Delphi consensus core outcome set for clinical trials in moderate-to-severe asthma (coreASTHMA)
    Tejwani, Vickram
    Chang, Hsing-Yuan
    Tran, Annie P.
    Al Naber, Jennifer
    Gutzwiller, Florian S.
    Winders, Tonya A.
    Khurana, Sandhya
    Sumino, Kaharu
    Mosnaim, Giselle
    Moloney, Rachael M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (01) : 116 - +
  • [28] Severe Asthma: Definition, Diagnosis and Treatment
    Lommatzsch, M.
    ALLERGOLOGIE, 2016, 39 (05) : 206 - 207
  • [29] WHO universal definition of severe asthma
    Bush, Andrew
    Zar, Heather J.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (02) : 115 - 121
  • [30] Severe Asthma Definition, Diagnosis and Treatment
    Muehlbauer, B.
    Sybrecht, G. W.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (35-36): : 601 - 601